This map shows the geographic impact of A Tompkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Tompkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Tompkins more than expected).
This network shows the impact of papers produced by A Tompkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Tompkins. The network helps show where A Tompkins may publish in the future.
Co-authorship network of co-authors of A Tompkins
This figure shows the co-authorship network connecting the top 25 collaborators of A Tompkins.
A scholar is included among the top collaborators of A Tompkins based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with A Tompkins. A Tompkins is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
17 of 17 papers shown
1.
Kohn, Elise C., E Reed, Gisele Sarosy, et al.. (2001). A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interaction.. PubMed. 7(6). 1600–9.48 indexed citations
2.
Figg, W D, William Dahut, Paul H. Duray, et al.. (2001). A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer.. PubMed. 7(7). 1888–93.243 indexed citations
Bergan, Raymond C., E Reed, Catherine E. Myers, et al.. (1999). A Phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer.. PubMed. 5(9). 2366–73.78 indexed citations
Bergan, Raymond C., William D. Figg, Nancy A. Dawson, et al.. (1997). Similar clinical outcomes in African-American and non-African-American males treated with suramin for metastatic prostate cancer.. PubMed. 89(9). 622–8.11 indexed citations
Dawson, Nancy A., Richard M. Lush, Seth M. Steinberg, et al.. (1996). Suramin-induced neutropenia. European Journal of Cancer. 32(9). 1534–1539.9 indexed citations
13.
Thibault, Alain, Dvorit Samid, A Tompkins, et al.. (1996). Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.. PubMed. 2(3). 483–91.321 indexed citations
Thibault, Alain, Michael R. Cooper, William D. Figg, et al.. (1994). A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer.. PubMed. 54(7). 1690–4.141 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.